2024年4月30日星期二

🌎 Geron Downgraded, Koninklijke Philips Upgraded, PVH Initiated and more...

Ratings changes for Jaguar Health, Marin Software, Iteris, Zillow Group, Intuit, Adverum Biotechnologies, Geron and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
April 30th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 


Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Citizens Financial Services (NASDAQ:CZFS) was upgraded by analysts at Janney Montgomery Scott from a "neutral" rating to a "buy" rating. They now have a $53.00 price target on the stock. This represents a 26.7% upside from the current price of $41.83.
  • Deciphera Pharmaceuticals (NASDAQ:DCPH) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $26.00 price target on the stock, up previously from $9.00. This represents a 2.8% upside from the current price of $25.29.
  • Hope Bancorp (NASDAQ:HOPE) was upgraded by analysts at DA Davidson from a "neutral" rating to a "buy" rating. They now have a $12.50 price target on the stock. This represents a 25.6% upside from the current price of $9.95.
  • MSCI (NYSE:MSCI) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "neutral" rating. They now have a $525.00 price target on the stock, up previously from $425.00. This represents a 9.9% upside from the current price of $477.86.
  • Koninklijke Philips (NYSE:PHG) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating.The current price is $26.72.
  • Koninklijke Philips (NYSE:PHG) was upgraded by analysts at UBS Group AG from a "sell" rating to a "neutral" rating.The current price is $26.72.
  • UMB Financial (NASDAQ:UMBF) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $95.00 price target on the stock. This represents a 21.9% upside from the current price of $77.91.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Boeing (NYSE:BA) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.The current price is $172.84.
  • Chegg (NYSE:CHGG) was downgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to an "underperform" rating. They now have a $4.00 price target on the stock, down previously from $7.00. This represents a 32.1% downside from the current price of $5.89.
  • Geron (NASDAQ:GERN) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $4.50 price target on the stock. This represents a 11.4% upside from the current price of $4.04.
  • Paramount Global (NASDAQ:PARA) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.The current price is $11.91.
  • XP (NASDAQ:XP) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $23.00 price target on the stock, down previously from $30.00. This represents a 7.4% upside from the current price of $21.42.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Adverum Biotechnologies (NASDAQ:ADVM) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $30.00 price target on the stock. This represents a 195.3% upside from the current price of $10.16.
  • ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $25.00 price target on the stock. This represents a 52.6% upside from the current price of $16.38.
  • Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $29.00 price target on the stock. This represents a 86.3% upside from the current price of $15.57.
  • Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $25.00 price target on the stock. This represents a 60.6% upside from the current price of $15.57.
  • Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $30.00 price target on the stock. This represents a 92.7% upside from the current price of $15.57.
  • Precision BioSciences (NASDAQ:DTIL) is now covered by analysts at Guggenheim. They set a "buy" rating and a $19.00 price target on the stock. This represents a 92.3% upside from the current price of $9.88.
  • Dyne Therapeutics (NASDAQ:DYN) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $40.00 price target on the stock. This represents a 57.2% upside from the current price of $25.44.
  • Excelerate Energy (NYSE:EE) is now covered by analysts at Stephens. They set an "overweight" rating and a $21.00 price target on the stock. This represents a 22.4% upside from the current price of $17.15.
  • Integral Ad Science (NASDAQ:IAS) is now covered by analysts at Loop Capital. They set a "buy" rating and a $15.00 price target on the stock. This represents a 54.3% upside from the current price of $9.72.
  • Immunome (NASDAQ:IMNM) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $24.00 price target on the stock. This represents a 68.4% upside from the current price of $14.25.
  • Iteris (NASDAQ:ITI) is now covered by analysts at Maxim Group. They set a "buy" rating and a $11.00 price target on the stock. This represents a 145.0% upside from the current price of $4.49.
  • Lexicon Pharmaceuticals (NASDAQ:LXRX) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $5.00 price target on the stock. This represents a 216.5% upside from the current price of $1.58.
  • MINISO Group (NYSE:MNSO) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $30.00 price target on the stock. This represents a 30.5% upside from the current price of $22.98.
  • Ovid Therapeutics (NASDAQ:OVID) is now covered by analysts at B. Riley. They set a "buy" rating and a $9.00 price target on the stock. This represents a 165.5% upside from the current price of $3.39.
  • PVH (NYSE:PVH) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating and a $115.00 price target on the stock. This represents a 1.9% upside from the current price of $112.90.
  • Ralph Lauren (NYSE:RL) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $195.00 price target on the stock. This represents a 16.7% upside from the current price of $167.03.
  • Red Robin Gourmet Burgers (NASDAQ:RRGB) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $16.00 price target on the stock. This represents a 112.5% upside from the current price of $7.53.
  • Telesat (NASDAQ:TSAT) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $9.00 price target on the stock. This represents a 26.1% upside from the current price of $7.14.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: Biden to drop out; finish out his term?

没有评论:

发表评论